DK0799043T3 - Cyklofasisk hormonel kur indeholdende antiprogestin og progestin - Google Patents

Cyklofasisk hormonel kur indeholdende antiprogestin og progestin

Info

Publication number
DK0799043T3
DK0799043T3 DK95943476T DK95943476T DK0799043T3 DK 0799043 T3 DK0799043 T3 DK 0799043T3 DK 95943476 T DK95943476 T DK 95943476T DK 95943476 T DK95943476 T DK 95943476T DK 0799043 T3 DK0799043 T3 DK 0799043T3
Authority
DK
Denmark
Prior art keywords
antiprogestin
progestin
estrogen
effective
cyclophasic
Prior art date
Application number
DK95943476T
Other languages
English (en)
Inventor
Gary Ph M P H Grubb
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK0799043T3 publication Critical patent/DK0799043T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK95943476T 1994-12-19 1995-12-15 Cyklofasisk hormonel kur indeholdende antiprogestin og progestin DK0799043T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/359,159 US5521166A (en) 1994-12-19 1994-12-19 Antiprogestin cyclophasic hormonal regimen
PCT/US1995/016561 WO1996019227A1 (en) 1994-12-19 1995-12-15 Cyclophasic hormonal regimen containing antiprogestin and progestin

Publications (1)

Publication Number Publication Date
DK0799043T3 true DK0799043T3 (da) 2004-08-09

Family

ID=23412581

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95943476T DK0799043T3 (da) 1994-12-19 1995-12-15 Cyklofasisk hormonel kur indeholdende antiprogestin og progestin

Country Status (11)

Country Link
US (1) US5521166A (da)
EP (1) EP0799043B1 (da)
JP (1) JPH10513152A (da)
AT (1) ATE264682T1 (da)
AU (1) AU711179B2 (da)
CA (1) CA2208007A1 (da)
DE (1) DE69532927T2 (da)
DK (1) DK0799043T3 (da)
ES (1) ES2219673T3 (da)
PT (1) PT799043E (da)
WO (1) WO1996019227A1 (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506390B2 (en) 1996-06-25 2003-01-14 Akzo Nobel Progestogen-anti-progestogen regimens
US20020012694A1 (en) * 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
AU747710B2 (en) * 1997-11-14 2002-05-23 Akzo Nobel N.V. Progestogen-antiprogestogen regimens
ES2226833T3 (es) * 1999-05-04 2005-04-01 Wyeth Composiciones anticonceptivas que contienen agentes antiprogestinicos y progestinicos.
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6355648B1 (en) * 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6329416B1 (en) * 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6391907B1 (en) * 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
EP1173213A1 (en) * 1999-05-04 2002-01-23 American Home Products Corporation Compositions containing benzimidazolones and progestogens
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
AU2003261233A1 (en) * 2002-07-25 2004-02-16 Massachusetts Institute Of Technology Steroid modulators in the treatment of peripheral nerve sheath tumors
KR20050059092A (ko) * 2002-08-28 2005-06-17 로버트 캐스퍼 에스트로겐 보충 요법
US20060052354A1 (en) * 2002-11-05 2006-03-09 Corcept Therapeutics, Inc. Methods for treating migraine
CA2504751C (en) * 2002-11-05 2013-02-05 Corcept Therapeutics, Inc. Methods for treating gastroesophageal reflux disease
US20060111318A1 (en) * 2003-04-18 2006-05-25 Advanced Medicine Research Institute Agent for treating eye diseases
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
MY150763A (en) * 2006-10-24 2014-02-28 Repros Therapeutics Inc Compositions and methods for suppressing endometrial proliferation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
US4780461A (en) * 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
AU580843B2 (en) * 1985-02-07 1989-02-02 Schering Aktiengesellschaft 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
DE3708942A1 (de) * 1987-03-18 1988-09-29 Schering Ag 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE19975054I2 (de) * 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
US5256421A (en) * 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
DE3744054A1 (de) * 1987-12-21 1989-06-29 Schering Ag Verwendung von antigestagenen zur herstellung von arzneimitteln
MX9301121A (es) * 1992-03-02 1993-09-01 Schering Ag Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina.
WO1993021926A1 (en) * 1992-05-06 1993-11-11 Medical College Of Hampton Roads Minimizing progestin associated breakthrough bleeding
ZA935617B (en) * 1992-08-14 1994-03-07 Akzo Nv Antiprogestogen containing contraceptives.

Also Published As

Publication number Publication date
EP0799043A1 (en) 1997-10-08
ES2219673T3 (es) 2004-12-01
ATE264682T1 (de) 2004-05-15
PT799043E (pt) 2004-08-31
WO1996019227A1 (en) 1996-06-27
AU711179B2 (en) 1999-10-07
DE69532927D1 (de) 2004-05-27
JPH10513152A (ja) 1998-12-15
AU4473096A (en) 1996-07-10
DE69532927T2 (de) 2005-04-14
EP0799043B1 (en) 2004-04-21
CA2208007A1 (en) 1996-06-27
US5521166A (en) 1996-05-28

Similar Documents

Publication Publication Date Title
PT799043E (pt) Regime hormonal ciclofasico contendo antiprogestina e progestina
ES2200384T3 (es) Medio anticonceptivo hormonal.
NO986104D0 (no) Progesteron-anti-progesteron regimer
ATE114116T1 (de) Kontinuierliche verabreichung des luteinisierendes hormon abgebenden hormons in kombination mit sexsteroidverabreichung als empfängnisverhütungsmittel.
BR0011740A (pt) Administração de esteróides androgênicos não-orais a mulheres
AR035564A1 (es) Moduladores selectivos de receptores de estrogenos en combinacion con estrogenos
DK0836506T4 (da) Transdermalt plaster til indgivelse af 17-deacetyl norgestimat alene eller i kombination med et østrogen
YU54602A (sh) Drospirenon za terapiju zamene hormona
AR016502A1 (es) Uso de sulfamatos estrogenos biogenicos en una terapia de reemplazo de hormonas.
NO970309L (no) Anvendelse av en progesteronantagonist og av et gestagen for behandling av endometriose eller Leiomyomata uteri
DE60104194D1 (de) Kombination der progesteron und mifepristone für krebs-therapie
CA2248841C (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
MY121568A (en) Use of a gnrh antagonist for the preparation of a medicament for the treatment of gonadal-steroid conditions
EP1605924B1 (en) Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
Fioretti et al. Prevention of Postmenopausal Bone Loss and Endometrial Responses during a Two Year Prospective Study with Transdermal 17β‐Estradiol and Oral Medroxyprogesterine Acetate
TH28358A (th) วิธีลด ldl คอเลสเทอรอล ภายหลังวัยหมดระดู
US7629334B1 (en) Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)
Notelovitz Management of the Late Menopause: Ultra Low-Dose Adjustive Estrogen Therapy
AR002283A1 (es) Composiciones para inyectar una vez al mes, que constituye un medicamento anticonceptivo de accion prolongada, apta para la terapia de reemplazo dehormonas en mujeres perimenopausicas y premonopausicas.
Lesca et al. Hepatocellular effects of progestogens used in hormone replacement
Naessen et al. F088 Bone loss in women over 60 years prevented by ultra-low doses of 17-β estradiol
Anderson et al. F089 The effects of surgical menopause and parenteral hormone replacement therapy on bone density, menopausal symptoms and hormone profiles
MXPA98007513A (en) Sequencial combination of estrogen / antagonist of progesterone for therapy of replacement of hormo
BR0010968A (pt) Preparação farmacêutica, embalagem farmacêutica, método de tratamento e uso de uma substância estrogenicamente ativa e substância progestogenicamente ativa na preparação de um medicamento